4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0001193125-26-144067
Chief Legal Officer sold 5,956 shares at $24.58 ($146,398)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bellon Christine Chief Legal Officer | 2026-04-01 | Sale 10b5-1 | −5,956 | $24.58 | $146,398 | 109,711 | D: show line 1 in the form |
| Open-market sales · 5,956 sh · avg $24.58 · $146,398 | |||||||
Loading xslF345X06/ownership.xml…